INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,967,357 | +138.0% | 196,727 | +98.9% | 0.01% | +150.0% |
| Q2 2023 | $2,086,874 | -48.4% | 98,904 | -58.3% | 0.00% | -50.0% |
| Q1 2023 | $4,047,107 | -52.6% | 237,367 | -44.4% | 0.00% | -55.6% |
| Q4 2022 | $8,537,114 | -37.8% | 427,283 | -32.9% | 0.01% | -43.8% |
| Q3 2022 | $13,721,000 | +85.7% | 636,993 | +70.0% | 0.02% | +77.8% |
| Q2 2022 | $7,388,000 | +6.2% | 374,646 | +26.6% | 0.01% | +28.6% |
| Q1 2022 | $6,956,000 | -15.9% | 295,993 | -2.5% | 0.01% | 0.0% |
| Q4 2021 | $8,274,000 | -17.5% | 303,730 | -16.6% | 0.01% | -22.2% |
| Q3 2021 | $10,024,000 | -16.8% | 363,984 | -14.0% | 0.01% | -10.0% |
| Q2 2021 | $12,043,000 | -52.8% | 423,146 | -43.6% | 0.01% | -60.0% |
| Q1 2021 | $25,538,000 | -23.5% | 749,809 | -25.2% | 0.02% | -16.7% |
| Q4 2020 | $33,373,000 | -35.7% | 1,002,497 | -37.9% | 0.03% | -43.4% |
| Q3 2020 | $51,908,000 | +7.8% | 1,615,050 | -7.6% | 0.05% | -7.0% |
| Q2 2020 | $48,132,000 | +34.2% | 1,747,707 | -21.9% | 0.06% | +1.8% |
| Q1 2020 | $35,857,000 | -50.7% | 2,236,848 | -26.6% | 0.06% | -32.5% |
| Q4 2019 | $72,751,000 | +57.6% | 3,046,475 | +16.4% | 0.08% | +45.6% |
| Q3 2019 | $46,151,000 | -20.7% | 2,616,306 | +15.1% | 0.06% | -20.8% |
| Q2 2019 | $58,213,000 | +208.8% | 2,273,947 | +250.6% | 0.07% | +200.0% |
| Q1 2019 | $18,854,000 | +991.7% | 648,566 | +392.4% | 0.02% | +1100.0% |
| Q4 2018 | $1,727,000 | -46.0% | 131,706 | -16.7% | 0.00% | -50.0% |
| Q3 2018 | $3,197,000 | -63.4% | 158,115 | -57.2% | 0.00% | -63.6% |
| Q2 2018 | $8,735,000 | +31.9% | 369,325 | +25.6% | 0.01% | +22.2% |
| Q1 2018 | $6,620,000 | -58.1% | 293,978 | -42.1% | 0.01% | -59.1% |
| Q4 2017 | $15,818,000 | -37.7% | 507,325 | -37.6% | 0.02% | -43.6% |
| Q3 2017 | $25,391,000 | +878.5% | 813,562 | +438.0% | 0.04% | +875.0% |
| Q2 2017 | $2,595,000 | -5.0% | 151,230 | -3.1% | 0.00% | -20.0% |
| Q1 2017 | $2,732,000 | +53.7% | 156,005 | +16.1% | 0.01% | +66.7% |
| Q4 2016 | $1,777,000 | -8.9% | 134,322 | -0.0% | 0.00% | 0.0% |
| Q3 2016 | $1,951,000 | +1.4% | 134,382 | -31.2% | 0.00% | -25.0% |
| Q2 2016 | $1,925,000 | +23.7% | 195,258 | +59.0% | 0.00% | +33.3% |
| Q1 2016 | $1,556,000 | -62.5% | 122,819 | -46.3% | 0.00% | -50.0% |
| Q4 2015 | $4,153,000 | -35.7% | 228,885 | -34.2% | 0.01% | -33.3% |
| Q3 2015 | $6,463,000 | -1.6% | 348,012 | +29.4% | 0.01% | -10.0% |
| Q2 2015 | $6,570,000 | +145.7% | 269,012 | +109.2% | 0.01% | +150.0% |
| Q1 2015 | $2,674,000 | -36.2% | 128,575 | -52.5% | 0.00% | -20.0% |
| Q4 2014 | $4,188,000 | +1176.8% | 270,750 | +975.7% | 0.01% | – |
| Q3 2014 | $328,000 | -92.1% | 25,170 | -87.9% | 0.00% | -100.0% |
| Q2 2014 | $4,140,000 | +181.6% | 207,221 | +168.4% | 0.01% | +200.0% |
| Q1 2014 | $1,470,000 | +352.3% | 77,217 | +304.7% | 0.00% | – |
| Q4 2013 | $325,000 | -28.4% | 19,079 | -34.4% | 0.00% | -100.0% |
| Q3 2013 | $454,000 | +107.3% | 29,074 | +58.5% | 0.00% | – |
| Q2 2013 | $219,000 | – | 18,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |